The management of invasive fungal infections has been hampered by the inability to
diagnose the infection at an early stage of disease. Although proving the presence of …

Human fungal pathogens that cause invasive infections are hidden killers, taking lives of
one and a half million people every year. However, research progress in this field has not …

Pathogenic fungi are the cause of life-threatening infections in an increasing number of
immunocompromised patients. The intrinsic resistance to antifungal therapy observed in …

The frequency of nosocomial mycoses has substantially increased in recent years, primarily
because of the use of intensive therapeutic regimens in patients with cancer and organ …

Invasive fungal infections continue to be a major cause of morbidity and mortality in
immunocompromised or severely ill patients. This report highlights new research data …

What is known and Objective: Invasive fungal infections (IFI) are associated with high rates
of morbidity and mortality, particularly in onco‐haematology patients. We aimed to study the …

Systemic mycoses continue to emerge as life-threatening infections. Considerable progress
in treating these infections is being achieved through better application of established …

Highlights•Invasive fungal infections have high mortality, and are increasingly drug
resistant.•Immunotherapy is a rational approach for fungal disease in immunocompromised.• …

Fungal infections cause morbidity worldwide and are associated with an unacceptably high
mortality despite the availability of antifungal drugs. The incidence of mycoses is rising …

Interactions between fungi and bacteria and their relevance to human health and disease
have recently attracted increased attention in biomedical fields. Emerging evidence shows …